ADAPT and Improvise: Overcoming Bacillus Calmette-Guérin Unresponsiveness in Non–muscle-invasive Bladder Cancer
- 1 June 2023
- journal article
- editorial
- Published by Elsevier BV in European Urology
- Vol. 83 (6), 495-496
- https://doi.org/10.1016/j.eururo.2023.02.018
Abstract
No abstract availableFunding Information
- Manchester Biomedical Research Centre
This publication has 10 references indexed in Scilit:
- A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER StudyEuropean Urology, 2023
- Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized StudyJournal of Clinical Oncology, 2023
- Pushing the Envelope: The Role of Radiation Therapy in Non-muscle-Invasive Bladder CancerSeminars in Radiation Oncology, 2023
- NRG Oncology/RTOG 0926: Phase II Protocol for Patients With Stage T1 Bladder Cancer to Evaluate Selective Bladder Preserving Treatment by Radiation Therapy Concurrent With Radiosensitizing Chemotherapy Following a Thorough Transurethral Surgical Re-StagingInternational Journal of Radiation Oncology*Biology*Physics, 2021
- Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trialsThe Lancet Oncology, 2021
- PD-L1 and BCG response predictionNature Reviews Urology, 2019
- Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate CancerJournal of Clinical Oncology, 2018
- Dose-limiting Urinary Toxicity With Pembrolizumab Combined With Weekly Hypofractionated Radiation Therapy in Bladder CancerInternational Journal of Radiation Oncology*Biology*Physics, 2018
- Definitions, End Points, and Clinical Trial Designs for Non–Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer GroupJournal of Clinical Oncology, 2016
- A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of medical research council trial BA09International Journal of Radiation Oncology*Biology*Physics, 2000